TIL Therapy Explained by Steven Rosenberg, MD, PhD
Much of the excitement revolving around cancer immunotherapy is focused on checkpoint inhibitors – drugs that “release the brakes”...
Category: AACR
Much of the excitement revolving around cancer immunotherapy is focused on checkpoint inhibitors – drugs that “release the brakes”...
Cancer patient advocates take on many roles in their communities. They may go out to churches to promote the...
Dong-Joo (Ellen) Cheon, PhD, Assistant Professor of Regenerative and Cancer Cell Biology at Albany Medical College and the 2017...
Thanks to decades of cancer research that have brought us groundbreaking discoveries and treatments, 15.5 million U.S. cancer survivors...
The lung cancer death rate—the number of lung cancer deaths per 100,000 U.S. men and women—has been decreasing slowly...
Back for the month of October are the editors’ picks from the eight esteemed scientific journals published by the...
For the third year running, the American Association for Cancer Research (AACR) has been selected as the beneficiary of...
On Friday, Margaret Foti, PhD, MD (hc), chief executive officer of the American Association for Cancer Research, was honored...
Breast cancer is the most commonly diagnosed cancer in the United States. In 2018, 266,120 women and 2,550 men...
The 30th Anniversary AACR Special Conference Convergence: Artificial Intelligence, Big Data, and Prediction in Cancer is focusing on a...